Literature DB >> 10198162

cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse.

T Oki1, K Yamazaki, J Kuromitsu, M Okada, I Tanaka.   

Abstract

We subcloned human and mouse full-length cDNAs of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT), which was designated GFAT2 (the previously reported GFAT was named GFAT1). Both the human and the mouse GFAT2 proteins deduced from their open reading frame sequences are composed of 682 amino acids of approximately 77.0 kDa. At the amino acid level, homologies between the human GFAT1 and GFAT2, between the mouse GFAT1 and GFAT2, and between the human GFAT2 and the mouse GFAT2 were 75.6, 74.7, and 97. 2%, respectively. Northern blot analysis using probe specific to human GFAT1 or GFAT2 showed that major transcripts were approximately 3.0 kb in both the human GFAT subtypes. The analysis also revealed different tissue distribution between GFAT1 and GFAT2: GFAT1 was more highly expressed in the placenta, pancreas, and testis than GFAT2; GFAT2 was expressed throughout the central nervous system, especially in the spinal cord, but GFAT1 expression was weak. The locus was mapped to human chromosome 5q and mouse chromosome 11, where a synteny between the two species has been known. GFAT2 can provide insights into understanding the roles of the hexosamine pathway in various tissues, particularly with the development of glucose toxicity and diabetes complications. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198162     DOI: 10.1006/geno.1999.5785

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  52 in total

Review 1.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

2.  Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.

Authors:  Stéphanie Bauché; Geoffroy Vellieux; Damien Sternberg; Marie-Joséphine Fontenille; Elodie De Bruyckere; Claire-Sophie Davoine; Guy Brochier; Julien Messéant; Lucie Wolf; Michel Fardeau; Emmanuelle Lacène; Norma Romero; Jeanine Koenig; Emmanuel Fournier; Daniel Hantaï; Nathalie Streichenberger; Veronique Manel; Arnaud Lacour; Aleksandra Nadaj-Pakleza; Sylvie Sukno; Françoise Bouhour; Pascal Laforêt; Bertrand Fontaine; Laure Strochlic; Bruno Eymard; Frédéric Chevessier; Tanya Stojkovic; Sophie Nicole
Journal:  J Neurol       Date:  2017-07-15       Impact factor: 4.849

3.  O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats.

Authors:  Rodrigo Pacheco Silva-Aguiar; Nathália C F Bezerra; Miguel C Lucena; Gabriela M Sirtoli; Roberto T Sudo; Gisele Zapata-Sudo; Christina M Takiya; Ana Acacia S Pinheiro; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

4.  Functional regulation of glutamine:fructose-6-phosphate aminotransferase 1 (GFAT1) of Drosophila melanogaster in a UDP-N-acetylglucosamine and cAMP-dependent manner.

Authors:  H R Graack; U Cinque; H Kress
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

5.  Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes.

Authors:  Pascale Anderle; Thierry Sengstag; David M Mutch; Martin Rumbo; Viviane Praz; Robert Mansourian; Mauro Delorenzi; Gary Williamson; Matthew-Alan Roberts
Journal:  BMC Genomics       Date:  2005-05-10       Impact factor: 3.969

Review 6.  Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.

Authors:  Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias
Journal:  J Bioenerg Biomembr       Date:  2018-01-11       Impact factor: 2.945

Review 7.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

8.  Computational prediction and experimental validation of evolutionarily conserved microRNA target genes in bilaterian animals.

Authors:  Kahori Takane; Kosuke Fujishima; Yuka Watanabe; Asako Sato; Nobuto Saito; Masaru Tomita; Akio Kanai
Journal:  BMC Genomics       Date:  2010-02-09       Impact factor: 3.969

9.  Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Authors:  Todd L Edwards; William K Scott; Cherylyn Almonte; Amber Burt; Eric H Powell; Gary W Beecham; Liyong Wang; Stephan Züchner; Ioanna Konidari; Gaofeng Wang; Carlos Singer; Fatta Nahab; Burton Scott; Jeffrey M Stajich; Margaret Pericak-Vance; Jonathan Haines; Jeffery M Vance; Eden R Martin
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

10.  Finding the missing link between the unfolded protein response and O-GlcNAcylation in the heart.

Authors:  Christopher C Glembotski
Journal:  Circ Res       Date:  2014-08-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.